SCHEMBL16626688

SCHEMBL16626688

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3c(F)cc(F)cc3Cl)ccc12

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
HTT P42858 2/20 0.37
IDE P14735 1/20 0.36
HTR6 P50406 7/20 0.34
POLB P06746 1/20 0.34
MAP3K8 P41279 2/20 0.33
TBXAS1 P24557 1/20 0.33
NAMPT P43490 3/20 0.33
JAK2 O60674 1/20 0.33
MAPK13 O15264 1/20 0.32
EIF2AK2 P19525 1/20 0.32
MAPK12 P53778 1/20 0.32
MAPK11 Q15759 1/20 0.32
MAPK14 Q16539 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618762 0.99 PDE4A (0.36) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL16626467 0.96 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DHTT
Hydrochloric Acid SCHEMBL16619112 0.95 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL16626705 0.94 IDE (0.38) PDE4APDE4BPDE4CPDE4DHTT
Hydrochloric Acid SCHEMBL16619146 0.93 IDE (0.37) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL16626691 0.91 HTT (0.38) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL16626463 0.90 IDE (0.36) PDE4APDE4BPDE4CPDE4DHTT
Hydrochloric Acid SCHEMBL16619096 0.90 HTT (0.38) PDE4APDE4BPDE4CPDE4DHTT
Hydrochloric Acid SCHEMBL16618652 0.89 IDE (0.35) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL16626709 0.89 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI PDE4A 2460/4885PDE4B 1996/4885PDE4C 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.